Thomas S Kilduff

Sri International

$32,452,921

Attributed

$34,739,093

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.6M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$34,739,093 · 18

By mechanism

R01$30,547,859 · 11

R21$4,191,234 · 7

Top collaborators

Most similar at Sri International

Same institution · by research overlap

Sarah Wurts Black$147,239

Others in their field

Top investigators on “Sleep”

Chanza Baytop · Westat, Inc.$271,217,917
Rebecca Montalvan · Westat, Inc.$86,600,000
Stanley Carlton Ahalt · Univ Of North Carolina Chapel Hill$78,409,067
Michael W Weiner · Northern California Institute Res &Educ$71,598,372
Susan S Redline · Brigham And Women'S Hospital$70,983,879
Richard Gibbs · Baylor College Of Medicine$68,573,551

Research focus

SleepNeuronsWakefulnessCellsElectroencephalographySleep DisordersBaseHypocretinBrainNarcolepsyReceptorNeurobiologyResponseRem SleepMouse ModelCataplexyArousalMediatingIn VitroAgonistAffectRattusSleep RegulationSleep Deprivation

Grant awards (73)

Nociceptin, NOPR and Sleep/Wake Control$839,815

R01 · FY2025 · NS · contact PI

Nociceptin, NOPR and Sleep/Wake Control$952,099

R01 · FY2024 · NS · contact PI

Neural Gene Expression in Sleep Deprivation and Recovery$1

R01 · FY2023 · HL · contact PI

Neural Gene Expression in Sleep Deprivation and Recovery$888,581

R01 · FY2022 · HL · contact PI

Mechanisms Underlying TAAR1-induced Wakefulness and REM Sleep Suppression$629,914

R01 · FY2022 · NS · contact PI

Neural Gene Expression in Sleep Deprivation and Recovery$886,540

R01 · FY2021 · HL · contact PI

Mechanisms Underlying TAAR1-induced Wakefulness and REM Sleep Suppression$645,843

R01 · FY2021 · NS · contact PI

Neural Gene Expression in Sleep Deprivation and Recovery$588,962

R01 · FY2021 · HL · contact PI

Neural Gene Expression in Sleep Deprivation and Recovery$884,483

R01 · FY2020 · HL · contact PI

The Tuberal Hypothalamus and Arousal State Control$654,768

R01 · FY2020 · NS · contact PI

Mechanisms Underlying TAAR1-induced Wakefulness and REM Sleep Suppression$654,133

R01 · FY2020 · NS · contact PI

Nociceptin/Orphanin FQ, NOPR and Sleep/Wake$645,873

R21 · FY2020 · NS · contact PI

Sleep, opiate withdrawal and the N/OFQ - NOP system$2,045,252

R01 · FY2019 · HL · contact PI

The Tuberal Hypothalamus and Arousal State Control$659,258

R01 · FY2019 · NS · contact PI

Mechanisms Underlying TAAR1-induced Wakefulness and REM Sleep Suppression$640,181

R01 · FY2019 · NS · contact PI

Hypocretin/orexin replacement with brain penetrant small molecule agonists$240,427

R21 · FY2019 · NS · contact PI

U.S.-Japan BRCP Supplement to "The Tuberal Hypothalamus and Arousal State Control"$35,320

R01 · FY2019 · NS · contact PI

The Tuberal Hypothalamus and Arousal State Control$702,694

R01 · FY2018 · NS · contact PI

Mechanisms Underlying TAAR1-induced Wakefulness and REM Sleep Suppression$641,847

R01 · FY2018 · NS · contact PI

Hypocretin/orexin replacement with brain penetrant small molecule agonists$290,241

R21 · FY2018 · NS · contact PI

Functional Genomics of Mammalian Hibernation$234,690

R21 · FY2018 · NS · contact PI

The Tuberal Hypothalamus and Arousal State Control$630,269

R01 · FY2017 · NS · contact PI

Neural Gene Expression in Sleep Deprivation and Recovery$498,500

R01 · FY2017 · HL · contact PI

Functional Genomics of Mammalian Hibernation$267,977

R21 · FY2017 · NS · contact PI

The Tuberal Hypothalamus and Arousal State Control$583,464

R01 · FY2016 · NS · contact PI

Neural Gene Expression in Sleep Deprivation and Recovery$493,500

R01 · FY2016 · HL · contact PI

Functional Connectivity of the Hypocretin/Orexin System$436,052

R01 · FY2016 · NS · contact PI

Neural Gene Expression in Sleep Deprivation and Recovery$487,230

R01 · FY2015 · HL · contact PI

TAAR1 agonists as wake-promoting and cognitive-enhancing therapeutics$473,598

R21 · FY2015 · NS · contact PI

TAAR1 and the Control of Wakefulness$448,442

R01 · FY2015 · NS · contact PI

Functional Connectivity of the Hypocretin/Orexin System$432,025

R01 · FY2015 · NS · contact PI

Imaging of Hippocampal Activity Across Sleep/Wake and Disease States$249,998

R21 · FY2015 · NS · contact PI

Travel support for U.S.-Japan Brain Research Colllaborative Program$19,168

R01 · FY2015 · NS · contact PI

Neural Gene Expression in Sleep Deprivation and Recovery$489,775

R01 · FY2014 · HL · contact PI

TAAR1 agonists as wake-promoting and cognitive-enhancing therapeutics$476,989

R21 · FY2014 · NS · contact PI

TAAR1 and the Control of Wakefulness$448,604

R01 · FY2014 · NS · contact PI

Functional Connectivity of the Hypocretin/Orexin System$423,816

R01 · FY2014 · NS · contact PI

Imaging of Hippocampal Activity Across Sleep/Wake and Disease States$299,784

R21 · FY2014 · NS · contact PI

TAAR1 Agonists as Narcolepsy Therapeutics$245,105

R21 · FY2014 · NS · contact PI

TAAR1 and the Control of Wakefulness$451,463

R01 · FY2013 · NS · contact PI

Functional Connectivity of the Hypocretin/Orexin System$414,307

R01 · FY2013 · NS · contact PI

TAAR1 Agonists as Narcolepsy Therapeutics$294,478

R21 · FY2013 · NS · contact PI

Neurobiological studies of gammahydroxybutyrate$439,764

R01 · FY2012 · NS · contact PI

Functional Connectivity of the Hypocretin/Orexin System$434,572

R01 · FY2012 · NS · contact PI

Neurobiological studies of gammahydroxybutyrate$434,324

R01 · FY2011 · NS · contact PI

Neural Gene Expression in Sleep Deprivation and Recovery$565,959

R01 · FY2010 · HL · contact PI

Neurobiological studies of gammahydroxybutyrate$467,072

R01 · FY2010 · NS · contact PI

Neural Gene Expression in Sleep Deprivation and Recovery$550,046

R01 · FY2009 · HL · contact PI

Neurobiological studies of gammahydroxybutyrate$499,794

R01 · FY2009 · NS · contact PI

Hypocretin agonists as treatments for narcolepsy and wakefulness promotion$216,016

R21 · FY2009 · NS · contact PI

Neurobiological studies of gammahydroxybutyrate$91,914

R01 · FY2009 · NS · contact PI

Neurobiological studies of gammahydroxybutyrate$91,100

R01 · FY2009 · NS · contact PI

Neurobiological studies of gammahydroxybutyrate$403,604

R01 · FY2008 · NS · contact PI

Hypocretin agonists as treatments for narcolepsy and wakefulness promotion$256,058

R21 · FY2008 · NS · contact PI

SLEEP, AGING, AND THE HYPOCRETIN/OREXIN SYSTEM$456,397

R01 · FY2007 · AG · contact PI

NEUROBIOLOGICAL STUDIES OF A NOVEL HYPOTHALAMIC PEPTIDE$439,330

R01 · FY2007 · MH · contact PI

NEURAL GENE EXPRESSION IN SLEEP DEPRIVATION AND RECOVERY$490,257

R01 · FY2006 · HL · contact PI

SLEEP, AGING, AND THE HYPOCRETIN/OREXIN SYSTEM$470,020

R01 · FY2006 · AG · contact PI

NEUROBIOLOGICAL STUDIES OF A NOVEL HYPOTHALAMIC PEPTIDE$449,463

R01 · FY2006 · MH · contact PI

NEURAL GENE EXPRESSION IN SLEEP DEPRIVATION AND RECOVERY$502,044

R01 · FY2005 · HL

SLEEP, AGING, AND THE HYPOCRETIN/OREXIN SYSTEM$481,306

R01 · FY2005 · AG

NEUROBIOLOGICAL STUDIES OF A NOVEL HYPOTHALAMIC PEPTIDE$452,647

R01 · FY2005 · MH

NEURAL GENE EXPRESSION IN SLEEP DEPRIVATION AND RECOVERY$500,827

R01 · FY2004 · HL

SLEEP, AGING, AND THE HYPOCRETIN/OREXIN SYSTEM$481,355

R01 · FY2004 · AG

NEUROBIOLOGICAL STUDIES OF A NOVEL HYPOTHALAMIC PEPTIDE$444,232

R01 · FY2004 · MH

NEURAL GENE EXPRESSION IN SLEEP DEPRIVATION AND RECOVERY$469,531

R01 · FY2003 · HL

SLEEP, AGING, AND THE HYPOCRETIN/OREXIN SYSTEM$427,212

R01 · FY2003 · AG

NEUROBIOLOGICAL STUDIES OF A NOVEL HYPOTHALAMIC PEPTIDE$312,861

R01 · FY2003 · MH

NEUROBIOLOGICAL STUDIES OF A NOVEL HYPOTHALAMIC PEPTIDE$303,750

R01 · FY2002 · MH

NEUROBIOLOGICAL STUDIES OF A NOVEL HYPOTHALAMIC PEPTIDE$294,903

R01 · FY2001 · MH

NEURAL GENE EXPRESSION IN SLEEP DEPRIVATION AND RECOVERY$423,947

R01 · FY2000 · HL

NEUROBIOLOGICAL STUDIES OF A NOVEL HYPOTHALAMIC PEPTIDE$286,311

R01 · FY2000 · MH

PRENATAL NICOTINE EXPOSURE, THE CIRCADIAN SYSTEM &SIDS$277,011

R01 · FY2000 · HL